The USFDA has approved pafolacianine as a supplement to ovarian cancer detection methods. The same is to be administered via intravenous injection before surgery, and the body is to be scanned under fluorescent light for tumors that may not have been detected earlier. Ovarian cancers are mainly removed surgically, and the prevention of metastasis or recurrence is dealt with chemotherapy. The current detection methods to identify tumors and metastasis include pre-surgical imaging and digital palpation during surgery.
However, some tumors may be difficult to detect through these methods, leading to incomplete treatment. Pafolacianine assisted imaging illuminates the difficult-to-detect tumors and thus, can change the dynamics of ovarian cancer treatment. Why was pafolacianine the choice of drug for ovarian cancer imaging? The rationale for using pafolacianine for imaging ovarian cancers…
